Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
2.050
-0.410 (-16.67%)
Jan 21, 2025, 4:00 PM EST - Market closed
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $18.29 million as of January 21, 2025. Its market cap has decreased by -60.49% in one year.
Market Cap
18.29M
Enterprise Value
10.54M
1-Year Change
-60.49%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $18.29M, a decrease of -60.06%. That is a compound annual growth rate of -10.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 17, 2025 | 22.00M | -20.86% |
Dec 31, 2024 | 27.80M | -43.15% |
Dec 29, 2023 | 48.90M | 120.27% |
Dec 30, 2022 | 22.20M | -71.86% |
Dec 31, 2021 | 78.90M | 13.36% |
Dec 31, 2020 | 69.60M | -47.15% |
Dec 31, 2019 | 131.70M | -47.70% |
Dec 31, 2018 | 251.80M | 509.69% |
Dec 29, 2017 | 41.30M | 27.08% |
Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 352.70B |
AbbVie | 303.17B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |